Evidence map›Paper›PMID 29691232›Full record

ArticleCirculation research2018

Topological Arrangement of Cardiac Fibroblasts Regulates Cellular Plasticity.

Jingyi Yu, Marcus M Seldin, Kai Fu, Shen Li, Larry Lam, Ping Wang, Yijie Wang, Dian Huang, Thang L Nguyen, Bowen Wei and 6 more

Abstract read
In one paragraph

Article in Circulation research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Engineering the maturation of stem cell-derived cardiomyocytes.Frontiers in bioengineering and biotechnology · 2023
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. How Chromatin Stiffens Fibroblasts.Current opinion in physiology · 2022
    Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 4 countries.

Jingyi YuFrom the Division of Cardiology, Department of Medicine (J.Y., M.M.S., S.L., P.W., Y.W., A.J.L., A.D.).
Marcus M SeldinFrom the Division of Cardiology, Department of Medicine (J.Y., M.M.S., S.L., P.W., Y.W., A.J.L., A.D.).
Kai FuDepartment of Molecular, Cell, and Developmental Biology (J.Y., K.F., S.L., L.L., P.W., Y.W., M.P., A.D.).
Shen LiFrom the Division of Cardiology, Department of Medicine (J.Y., M.M.S., S.L., P.W., Y.W., A.J.L., A.D.).
Larry LamDepartment of Molecular, Cell, and Developmental Biology (J.Y., K.F., S.L., L.L., P.W., Y.W., M.P., A.D.).
Ping WangFrom the Division of Cardiology, Department of Medicine (J.Y., M.M.S., S.L., P.W., Y.W., A.J.L., A.D.).
Yijie WangFrom the Division of Cardiology, Department of Medicine (J.Y., M.M.S., S.L., P.W., Y.W., A.J.L., A.D.).
Dian HuangDepartment of Bioengineering (D.H., T.L.N., D.D.C.).
Thang L NguyenDepartment of Bioengineering (D.H., T.L.N., D.D.C.).
Bowen WeiDivision of Dermatology, Department of Medicine, David Geffen School of Medicine (B.W., R.P.K.).
Rajan P KulkarniJonsson Comprehensive Cancer Center (J.Y., K.F., S.L., L.L., P.W., Y.W., R.P.K., D.D.C., M.T., M.P., A.D.).
Dino Di CarloJonsson Comprehensive Cancer Center (J.Y., K.F., S.L., L.L., P.W., Y.W., R.P.K., D.D.C., M.T., M.P., A.D.).
Michael TeitellMolecular Biology Institute (J.Y., K.F., S.L., L.L., P.W., Y.W., M.T., M.P., A.D.).
Matteo PellegriniDepartment of Molecular, Cell, and Developmental Biology (J.Y., K.F., S.L., L.L., P.W., Y.W., M.P., A.D.).
Aldons J LusisFrom the Division of Cardiology, Department of Medicine (J.Y., M.M.S., S.L., P.W., Y.W., A.J.L., A.D.).
Arjun DebFrom the Division of Cardiology, Department of Medicine (J.Y., M.M.S., S.L., P.W., Y.W., A.J.L., A.D.) adeb@mednet.ucla.edu.
UCLA Jonsson Comprehensive Cancer CenterBioengineering Center · RUCardiovascular Research Center · BRBroad Center · USLaboratory of Molecular Genetics · PL

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
ULTRASTRUCTURE OF THE INTIMA IN EARLY LESION FORMATIONP01HL030568 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FOGELMAN, ALAN M · 1985 to 2019
$55.2M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KITCHEN, SCOTT G · 1991 to 2018
$39.9M
UCLA SPORE in Brain CancerP50CA211015 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Yvonne Yu-Hsuan Chen · 2017 to 2026
$25.2M
RNA trafficking in mitochondriaR01GM073981 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Carla M Koehler, MICHAEL A TEITELL · 2006 to 2026
$5.1M
A Systems Approach to Dissect Genetic Basis of Heart FailureR01HL123295 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LUSIS, ALDONS JAKE, WANG, YIBIN · 2014 to 2017
$2.6M
Role of ABCC6 in cardivascular calcificationR01HL137241 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DEB, ARJUN · 2017 to 2020
$2.1M
(PQD5) Mass Profiling Melanoma Responses to Improve Therapy Choices and PrognosisR01CA185189 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI REED, JASON C, TEITELL, MICHAEL A · 2014 to 2017
$1.9M
Reverse Mitochondrial Genetics Enabled by BlastR01GM114188 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHIOU, PEI-YU, TEITELL, MICHAEL A · 2015 to 2018
$1.9M
Role of mesenchymal-endothelial-transition in cardiac hypertrophyR01HL129178 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DEB, ARJUN · 2015 to 2018
$1.5M
Identifying therapeutic strategies for the multisystem genetic disorder Pseudoxanthoma ElasticumR01AR075867 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DEB, ARJUN · 2020 to 2023
$1.4M
NCI NIH HHS P30 CA016042NCI NIH HHS P50 CA211015NCI NIH HHS R01 CA185189NHLBI NIH HHS P01 HL030568NHLBI NIH HHS R01 HL123295NHLBI NIH HHS R01 HL129178NHLBI NIH HHS R01 HL137241NIAID NIH HHS P30 AI028697NIAMS NIH HHS R01 AR075867NIGMS NIH HHS R01 GM073981NIGMS NIH HHS R01 GM114188
6 · The paper itself

Abstract

rationaleCardiac fibroblasts do not form a syncytium but reside in the interstitium between myocytes. This topological relationship between fibroblasts and myocytes is maintained throughout postnatal life until an acute myocardial injury occurs, when fibroblasts are recruited to, proliferate and aggregate in the region of myocyte necrosis. The accumulation or aggregation of fibroblasts in the area of injury thus represents a unique event in the life cycle of the fibroblast, but little is known about how changes in the topological arrangement of fibroblasts after cardiac injury affect fibroblast function.

objectiveThe objective of the study was to investigate how changes in topological states of cardiac fibroblasts (such as after cardiac injury) affect cellular phenotype. METHODS AND

resultsUsing 2 and 3-dimensional (2D versus 3D) culture conditions, we show that simple aggregation of cardiac fibroblasts is sufficient by itself to induce genome-wide changes in gene expression and chromatin remodeling. Remarkably, gene expression changes are reversible after the transition from a 3D back to 2D state demonstrating a topological regulation of cellular plasticity. Genes induced by fibroblast aggregation are strongly associated and predictive of adverse cardiac outcomes and remodeling in mouse models of cardiac hypertrophy and failure. Using solvent-based tissue clearing techniques to create optically transparent cardiac scar tissue, we show that fibroblasts in the region of dense scar tissue express markers that are induced by fibroblasts in the 3D conformation. Finally, using live cell interferometry, a quantitative phase microscopy technique to detect absolute changes in single cell biomass, we demonstrate that conditioned medium collected from fibroblasts in 3D conformation compared with that from a 2D state significantly increases cardiomyocyte cell hypertrophy.

conclusionsTaken together, these findings demonstrate that simple topological changes in cardiac fibroblast organization are sufficient to induce chromatin remodeling and global changes in gene expression with potential functional consequences for the healing heart.

Indexed as

Cell AggregationCell PlasticityChromatin Assembly and DisassemblyGene ExpressionAnimalsCell Culture TechniquesCulture Media, ConditionedFemaleFibroblastsMaleMiceMyocardial InfarctionMyocardiumMyocytes, CardiacPhenotypeCulture Media, Conditionedcell biologyfibroblastsfibrosishypertrophyinterferometry

Identifiers

PMID29691232
PMCPMC6014922
OpenAlexW2802903441

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.